Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Item affecting comparability in Q2 2019

Lund, Sweden, 18:00 CET 18 July 2019 BONESUPPORT will record an item affecting comparability with a negative impact of approximately SEK 11.0 million on operating profit in the second quarter 2019. The item is a provision related to product returns from the previous US distributor, Zimmer Biomet. The provision is based on first indications from Zimmer Biomet and all returns will undergo a review and approval process. We expect the amount to be fixed and agreed during the third quarter 2019.  The provision has no significant impact on previously communicated financial targets.

Dicot Receives Grant from Vinnova, Sweden’s Agency for Innovation, to Strengthen Intellectual Property Portfolio

Press release: Uppsala, June 18, 2019. Dicot AB (publ), developer of drugs targeting sexual dysfunction, today announced that the company has received a grant of SEK 100,000 from Vinnova's program "IP-checks Q2 2019" for Intellectual Property Review by Dicot AB.Vinnova is a government agency with the goal to aid Swedish companies to remain leading global players in research and innovation. Vinnova's IP-check program is part of the effort to strengthen the companies' awareness and knowledge of intellectual property rights and to help build strong IP portfolios. Dicot, with a process for

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 18.07.2019

United Bankers Corporation NOTIFICATION 18.07.2019 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 18.07.2019 Date 18.07.2019Exchange transaction BuyShare class UNIAVAmount 74Average price/share 8.1000 EURHighest price/share 8.1000 EURLowest price/share 8.1000 EURTotal price 599.40 EUR The shares held by United Bankers Corporation on 18.07.2019: UNIAV 24,306 On behalf of United Bankers Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

#19-983 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#19-982 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Ninjas in Pyjamas, Team Liquid, and Vitality invited to CORSAIR DreamHack Masters Malmö 2019

Joins already invited teams Fnatic, Astralis and qualified team Optic Gaming STOCKHOLM — DreamHack  today announced three new invites to the upcoming Counter-Strike: Global Offensive tournament CORSAIR DreamHack Masters Malmö, held in Malmö in October 2019. The new additions; Swedish superstars Ninjas in Pyjamas, number one ranked Team Liquid, and French team Vitality, join the already invited teams Fnatic and Astralis, as well as Optic Gaming, who earned their invitation by winning the DreamHack Open stop at DreamHack Summer.  Ninjas in Pyjamas has been

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Springfield, IL

Free youth baseball clinic to feature eight MLB AlumniColorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Sunday, July 21st, 2019. In conjunction with the Bank of Springfield , the free clinic features former Major League Baseball players who will teach baseball skills, drills and life lessons, concluding with an autograph session and baseball giveaways for children in attendance. Players attending*

Publication of a Prospectus

Investec Bank plc  Incorporated in England and Wales Registration number 489604 Date: 18 July 2019 Re:      Registration Document for Investec Bank plc (the "Registration Document") and Base Prospectus in respect of the £2,000,000,000 Impala Bonds Programme (the "Base Prospectus") Each of the Registration Document and Base Prospectus were approved on 17 July 2019 by the United Kingdom Financial Conduct Authority and are available for viewing. Copies of the Registration Document and the Base Prospectus are available at: i.   the registered office of the Issuer, Investec

Nolato Q2 2019: Normalised inventory situation at Integrated Solutions

Nolato AB has today published its interim report for the second quarter of 2019. · Sales totalled SEK 1,987 million (2,302) · Operating profit (EBITA) was SEK 233 million (266) · EBITA margin of 11.7% (11.6) · Profit after tax was SEK 180 million (204) · Basic earnings per share totalled SEK 6.82 (7.75) · Cash flow after investments amounted to SEK 178 million (352) · Sustained strong financial position Medical Solutions sales rose to SEK 634 million (562). Adjusted for currency, sales increased by a strong 9%. Operating profit (EBITA) rose to SEK 82 million (73).

Swiss Medical Network advances cancer care in Switzerland with multi-system agreement for Accuray radiation therapy systems and RaySearch oncology software systems

This is the first multi-system agreement by a hospital for both Accuray and RaySearch products. The Swiss Medical Network, Accuray and RaySearch have also partnered to expand opportunities for training healthcare professionals on the latest technologies.The Swiss Medical Network, one of Switzerland’s two largest private clinic groups, has signed a multi-system, multi-clinic agreement to purchase Accuray Incorporated’s radiation therapy delivery systems as well as RaySearch’s treatment planning system (TPS) and oncology information system (OIS). This is the first multi-system agreement by a

Ework Group, Interim Report, January - June 2019: New digital platformdeals, over 10,000 consultants on assignment

“For the first time, we achieved over 10,000 consultants on assignment, rolling annualised sales of SEK 12 billion, and can conclude that the scale of our operations has doubled since 2016, when we set our 2020 targets." Extract from CEO Zoran Covics commentary to the Interim Report.Second Quarter 2019 Compared to 2018 • Net sales increased by 13% to SEK 3,249 M (2,871). • EBIT was up by 14% to SEK 30.7 M (26.8). • Order intake rose by 8% to SEK 4,675 M (4,329). • Earnings per share after tax and after dilution were SEK 1.23 (1.15), a 7% increase. • Overall, the consulting

Interim report April - June 2019

"Overall a solid quarter"“During the second quarter of the year, sales increased by 7 percent, of which acquired units contributed 3 percentage points. Organic sales were unchanged compared with the year-earlier quarter, with variations between geographies. North and South America generally continued to perform well for us during the quarter, while the trend in Europe and Asia was more tentative, with increased uncertainty. Overall, The Group's earnings trend was stable, with the underlying EBIT increasing by 2 percentage points. The rate of investment remained at a high level, which

Interim report January-June 2019 – Pricer AB (publ)

- Continued growth in net sales and higher operating profitSecond quarter 2019 · Net sales of SEK 270.7 M (222.0), an increase of 22 percent compared to the same period last year. · Operating profit of SEK 34.1 M (20.1), which corresponds to an operating margin of 12.6 percent (9.0). · Order intake was SEK 230 M (520), a decrease of 56 percent compared to the same period last year. Last year’s order intake included a large order totaling more than SEK 300 M from an American customer. · Order backlog amounted to SEK 131 M (445), of which the majority is expected to be invoiced

Sobi completes acquisition of emapalumab and related assets

Following approvals from relevant competition authorities Swedish Orphan Biovitrum AB (publ)  (Sobi™) (STO:SOBI) has completed the acquisition of the newly established company owning emapalumab and related assets, as announced on 12 June 2019. The acquisition means that the previously announced exclusive licence agreement with Novimmune will be superseded. Through the acquisition of emapalumab, Sobi gains access to: · All assets relating to emapalumab including

INDUCT – LAST DAY OF SUBSCRIPTION PERIOD

Reference is made to the stock exchange announcement from Induct AS ("Induct" or the "Company") dated 21 June 2019, regarding an underwritten rights issue with gross proceeds up to NOK 1.9 million (the "Rights Issue") directed towards Eligible Shareholders and the announcement on 4 July 2019 regarding start of the subscription period for the Rights Issue. The subscription period for the Rights Issue ends today, 18 July 2019 at 16.30 hours (CET). Subscription rights that are not utilized within the end of the subscription period will lapse automatically and hold no value.

Länsförsäkringar Bank: January – June 2019

”The second quarter of 2019 was yet another successful quarter for Länsförsäkringar’s banking operations. Länsförsäkringar Bank reported strong financial earnings and continues to enjoy a high inflow of new customers. We also noted continued positive growth in business volumes in all business segments, which led to stable growth in market shares. A contributing factor to this success is our stated strategy of offering a complete solution in banking and insurance, both locally and digitally. We are convinced that the high level of customer satisfaction is the result of Länsförsäkringar’s

Länsförsäkringar Hypotek: January – June 2019

”Länsförsäkringar Hypotek continued to strengthen its position on the mortgage market. Mortgage volumes are increasing in line with the rising number of customers choosing Länsförsäkringar as their primary bank, at the same time as market shares are strengthening. Länsförsäkringar succeeded in advancing its positions despite a mortgage market that in the first half of the year was characterised by slightly lower market growth than in the preceding year. In April, Länsförsäkringar Hypotek became for the first time the player that captured the largest share of market growth in a single month

DreamHack Winter returns to Jönköping November 28-December 1, 2019

DreamHack Winter to be Longest DreamHack Festival Ever with 80 Hours of BYOC DreamHack Open to Feature $100,000 Prize Pool Live Music Concert to Feature Women-Led Metal Night Features DreamHack 25th Anniversary CelebrationSTOCKHOLM — Today, DreamHack  has announced it will return to Jönköping, Sweden for 2019 DreamHack Winter . The premier gaming lifestyle festival will celebrate its 25th anniversary during DreamHack Winter to honor the date of the very first DreamHack festival on December 9, 1994 — annually commemorated as “

Epiroc interim report Q2

April - June 2019 in brief · Orders received were SEK 10,553 million (10,483), organic decline of 4% · Revenues increased 8% to SEK 10,626 million (9,843), organic growth of 3% · Operating profit increased 25% to SEK 2,263 million (1,810) · Operating margin was 21.3% (18.4). Adjusted operating margin was 21.7%* · Basic earnings per share were SEK 1.40 (1.09) · Operating cash flow of SEK 1,506 million (199)CEO comments  Record-breaking quarterThe second quarter 2019 continued with positive deve-lopment for revenues and profit. Revenues increased 8% to an all-time

Aqilion receives SEK 100 million through conversion of outstanding warrants

In March of 2018, AQILION AB (formerly Partners för Utvecklingsinvesteringar inom Life Sciences, P.U.L.S. AB) carried out a directed issue of “units.” Each unit consisted of one (1) share and two (2) warrants. At that time, Aqilion raised SEK 100 million through subscription for shares. All outstanding warrants have now been converted to shares, which raised an additional SEK 100 million for the company. The issue was carried out to fund the restructuring of Aqilion’s strategy and organization, as well as the development of current and new pharmaceutical projects in the pipeline. “It is

Company announcement no. 75, 2019 – Supplement no. 1 to Base Prospectus

Nordea Kredit Realkreditaktieselskab hereby publishes supplement no. 1 to Base Prospectus for the Issuance of Mortgage Bonds (ROs) and Covered Mortgage Bonds (SDROs) for Nordea Kredit Realkreditaktieselskab dated 19 February 2019. The amendment to the Base Prospectus was a consequence of - the publication of the half year report 2019- the election of Head of Products and Development Marte Kopperstad to the Board of Directors of Nordea Realkreditaktieselskab and- minor adjustments to the text on negative interest rate so that fixed rate callable bonds with negative coupon (if

Half-year Financial Report of KONE Corporation for January-June 2019

KONE Corporation, stock exchange release, July 18, 2019 at 12.30 p.m. EEST Half-year Financial Report of KONE Corporation for January-June 2019 Continued strong orders received, well on track to meet full-year targets April-June 2019 -       Orders received grew by 9.0% to EUR 2,310 (4–6/2018: 2,119) million. At comparable exchange rates, orders grew by 8.1%. -       Sales grew by 9.0% to EUR 2,541 (2,331) million. At comparable exchange rates, sales grew by 7.9%. -       Operating income (EBIT) was EUR 306.5 (280.5) million or 12.1% (12.0%) of sales. The adjusted EBIT was

There are no items matching the current filter
There are no more items matching the current filter
Back to top